top of page


Melisa Institute
Sep 25, 20242 min read
MELISA Institute strengthens its leadership with new technological acquisitions for advanced research
In order to reaffirm our commitment to excellence in scientific research and high-precision diagnostics, this month we have added two new...


Melisa Institute
Jan 17, 20225 min read
Do official vital records of maternal death detect specific effects of new pandemic viruses?
A natural experiment carried out during the 2009 H1N1 pandemic found that vital records of births and maternal deaths in Argentine have...

Melisa Institute
Jun 4, 20214 min read
Study finds major anti-inflammatory immune activity that favors oral cancer tumors
Immunoregulatory activity, found in the tumor microenvironment, would be mediated by the vitamin D signaling pathway, opening a potential...


Melisa Institute
May 13, 20212 min read
MELISA Institute adds new infrared spectrophotometer IRSpirit to its R&D laboratory
In line with our objective of consolidating ourselves as one of the biotechnology R&D with the highest capacity in Chile, this month, at...


Melisa Institute
Mar 23, 20214 min read
MELISA'S EXPERIENCE - ASINOLAT: Characterization of the proteomic landscape of donkey's milk
Dr. Germán Errázuriz studied medicine at the University of Chile where he received his degree as a Surgeon. Then he made the specialty of...


Melisa Institute
Oct 29, 20202 min read
MELISA’s Experts: Our Core Facility in the words of its manager, Cristian Vargas, MD.
MELISA Institute's Core Facility is a services division aimed at providing personalized solutions to researchers and companies in the...


Melisa Institute
Sep 22, 20202 min read
MELISA's Experts: Bioinformatics applied to mass spectrometry, by Guillermo Nourdin, MSc.
MELISA Institute has first-level technology for the conservation, identification and subsequent analysis of research samples for...

Melisa Institute
Jul 27, 20208 min read
How safe is EGCG?
A brief analysis of Epigallocatechin-3-gallate, its benefits and its role in the fight against SARS-CoV-2 Epigallocatechin-3-gallate...
bottom of page